Cargando…
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
Autores principales: | Ecke, Thorsten H., Otto, Thomas, Le Calvez-Kelm, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766346/ https://www.ncbi.nlm.nih.gov/pubmed/33352845 http://dx.doi.org/10.3390/ijms21249657 |
Ejemplares similares
-
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision
por: Ecke, Thorsten H., et al.
Publicado: (2022) -
Illumination of a Vision 2020—Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions—Dream or Nightmare?
por: Ecke, Thorsten H., et al.
Publicado: (2020) -
Illumination of a Vision—How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research
por: Ecke, Thorsten H., et al.
Publicado: (2017) -
Improving our forecasts for trachoma elimination: What else do we need to know?
por: Pinsent, Amy, et al.
Publicado: (2017) -
Childhood Malnutrition: Where Does the World Stand? What Else is Needed?
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2016)